Schmidt J, Kaufmann B, Lindstaedt R, Szelenyi I
Department of Pharmacology, ASTA Pharma AG, Frankfurt, FRG.
Agents Actions. 1990 Nov;31(3-4):229-36. doi: 10.1007/BF01997613.
The effect of azelastine, an orally effective antiasthmatic antiallergic drug on the generation of oxygen-derived free radicals in phagocytes was investigated using different chemiluminescence-assays. The chemiluminescence (CL) of both human polymorphonuclear granulocytes (PMNL) and guinea-pig alveolar macrophages (AM) was induced either by phorbol myristate acetate (PMA) or zymosan and amplified either by lucigenin or DMNH (7-dimethylamino-naphthalene-1,2-dicarbonic-acidhydrazide). The inhibitory effect of azelastine was dependent on the inducer employed and the condition and type of cells used. Azelastine reduced PMA-induced CL concentration-dependently in both PMNL (IC30 = 3.9 microM) and AM (IC30 = 9.8 microM). In AM zymosan-induced CL was inhibited 21.7% by 10 microM azelastine, whereas in PMNL it remained unchanged up to 10 microM azelastine. Azelastine has a significantly stronger inhibitory effect (IC30 = 4.2 microM) on oxygen free radical generation in AM primed by fetal calf serum than in unprimed AM. Based on present results it is likely that azelastine inhibits oxygen-derived free radical generation by interaction with protein kinase C.
使用不同的化学发光测定法,研究了口服有效的抗哮喘抗过敏药物氮卓斯汀对吞噬细胞中氧衍生自由基生成的影响。人多形核粒细胞(PMNL)和豚鼠肺泡巨噬细胞(AM)的化学发光(CL)可由佛波酯肉豆蔻酸酯乙酸酯(PMA)或酵母聚糖诱导,并由光泽精或DMNH(7-二甲基氨基萘-1,2-二羧酸酰肼)放大。氮卓斯汀的抑制作用取决于所使用的诱导剂以及所用细胞的条件和类型。氮卓斯汀在PMNL(IC30 = 3.9 microM)和AM(IC30 = 9.8 microM)中均浓度依赖性地降低PMA诱导的CL。在AM中,10 microM氮卓斯汀可抑制酵母聚糖诱导的CL的21.7%,而在PMNL中,高达10 microM氮卓斯汀时其保持不变。与未预处理的AM相比,氮卓斯汀对胎牛血清预处理的AM中的氧自由基生成具有明显更强的抑制作用(IC30 = 4.2 microM)。根据目前的结果,氮卓斯汀可能通过与蛋白激酶C相互作用来抑制氧衍生自由基的生成。